Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_A8,12 | Lung | Primary cancer | 3,762 | Tumor/Malignant | 72.1% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_A8,13 | Lung | Primary cancer | 1,777 | Tumor/Malignant | 70.1% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__178_A8,14 | Lung | Primary cancer | 3,942 | Tumor/Malignant | 60.4% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__178_A8,15 | Lung | Primary cancer | 1,779 | Other | 26.7% | 0.84 | 0.38 |
| NSCLC_38242124__IMC__178_A8,16 | Lung | Primary cancer | 2,250 | Tumor/Malignant | 25.8% | 0.55 | 0.88 |
| NSCLC_38242124__IMC__178_A8,17 | Lung | Primary cancer | 3,942 | Tumor/Malignant | 58.4% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__178_A8,18 | Lung | Primary cancer | 3,562 | Tumor/Malignant | 51.3% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__178_A8,2 | Lung | Primary cancer | 2,798 | Tumor/Malignant | 36.1% | 0.95 | 0.23 |
| NSCLC_38242124__IMC__178_A8,3 | Lung | Primary cancer | 2,949 | Tumor/Malignant | 38.1% | 0.92 | 0.34 |
| NSCLC_38242124__IMC__178_A8,4 | Lung | Primary cancer | 2,687 | Tumor/Malignant | 93.7% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_A8,5 | Lung | Primary cancer | 3,785 | Tumor/Malignant | 33.1% | 0.98 | 0.12 |
| NSCLC_38242124__IMC__178_A8,6 | Lung | Primary cancer | 1,244 | Tumor/Malignant | 33.8% | 0.87 | 0.34 |
| NSCLC_38242124__IMC__178_A8,7 | Lung | Primary cancer | 1,427 | Tumor/Malignant | 72.8% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_A8,8 | Lung | Primary cancer | 2,823 | Tumor/Malignant | 47.0% | 0.92 | 0.23 |
| NSCLC_38242124__IMC__178_B1,1 | Lung | Primary cancer | 2,934 | Tumor/Malignant | 88.9% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_B1,10 | Lung | Primary cancer | 2,254 | Tumor/Malignant | 45.9% | 0.89 | 0.36 |
| NSCLC_38242124__IMC__178_B1,11 | Lung | Primary cancer | 2,507 | Tumor/Malignant | 66.8% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__178_B1,12 | Lung | Primary cancer | 2,308 | Stromal | 26.7% | 0.73 | 0.67 |
| NSCLC_38242124__IMC__178_B1,13 | Lung | Primary cancer | 284 | Tumor/Malignant | 69.7% | 0.50 | 0.68 |
| NSCLC_38242124__IMC__178_B1,14 | Lung | Primary cancer | 2,785 | Stromal | 33.2% | 0.52 | 0.76 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_A8,12 | Lung | Primary cancer | 3,762 | Tumor/Malignant | 76.4% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__178_A8,13 | Lung | Primary cancer | 1,777 | Tumor/Malignant | 62.9% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__178_A8,14 | Lung | Primary cancer | 3,942 | Tumor/Malignant | 41.8% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__178_A8,15 | Lung | Primary cancer | 1,779 | Stromal | 27.1% | 0.87 | 0.28 |
| NSCLC_38242124__IMC__178_A8,16 | Lung | Primary cancer | 2,250 | Tumor/Malignant | 24.1% | 0.58 | 0.86 |
| NSCLC_38242124__IMC__178_A8,17 | Lung | Primary cancer | 3,942 | Tumor/Malignant | 52.1% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__178_A8,18 | Lung | Primary cancer | 3,562 | Tumor/Malignant | 43.5% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__178_A8,2 | Lung | Primary cancer | 2,798 | Tumor/Malignant | 30.6% | 0.98 | 0.14 |
| NSCLC_38242124__IMC__178_A8,3 | Lung | Primary cancer | 2,949 | Tumor/Malignant | 33.0% | 0.93 | 0.28 |
| NSCLC_38242124__IMC__178_A8,4 | Lung | Primary cancer | 2,687 | Tumor/Malignant | 92.5% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_A8,5 | Lung | Primary cancer | 3,785 | Tumor/Malignant | 32.4% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__178_A8,6 | Lung | Primary cancer | 1,244 | Tumor/Malignant | 33.4% | 0.87 | 0.33 |
| NSCLC_38242124__IMC__178_A8,7 | Lung | Primary cancer | 1,427 | Tumor/Malignant | 76.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__178_A8,8 | Lung | Primary cancer | 2,823 | Tumor/Malignant | 47.0% | 0.92 | 0.23 |
| NSCLC_38242124__IMC__178_B1,1 | Lung | Primary cancer | 2,934 | Tumor/Malignant | 81.3% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__178_B1,10 | Lung | Primary cancer | 2,254 | Tumor/Malignant | 37.7% | 0.93 | 0.28 |
| NSCLC_38242124__IMC__178_B1,11 | Lung | Primary cancer | 2,507 | Tumor/Malignant | 58.5% | 0.98 | 0.05 |
| NSCLC_38242124__IMC__178_B1,12 | Lung | Primary cancer | 2,308 | Stromal | 27.9% | 0.73 | 0.71 |
| NSCLC_38242124__IMC__178_B1,13 | Lung | Primary cancer | 284 | Tumor/Malignant | 69.7% | 0.50 | 0.68 |
| NSCLC_38242124__IMC__178_B1,14 | Lung | Primary cancer | 2,785 | Tumor/Malignant | 28.4% | 0.96 | 0.15 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_A8,12 | Lung | Primary cancer | 3,762 | Tumor/Malignant cell | 76.0% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__178_A8,13 | Lung | Primary cancer | 1,777 | Tumor/Malignant cell | 70.6% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__178_A8,14 | Lung | Primary cancer | 3,942 | Tumor/Malignant cell | 60.7% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__178_A8,15 | Lung | Primary cancer | 1,779 | Fibroblast | 26.2% | 0.86 | 0.31 |
| NSCLC_38242124__IMC__178_A8,16 | Lung | Primary cancer | 2,250 | Tumor/Malignant cell | 25.2% | 0.86 | 0.43 |
| NSCLC_38242124__IMC__178_A8,17 | Lung | Primary cancer | 3,942 | Tumor/Malignant cell | 58.7% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__178_A8,18 | Lung | Primary cancer | 3,562 | Tumor/Malignant cell | 51.3% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__178_A8,2 | Lung | Primary cancer | 2,798 | Tumor/Malignant cell | 36.2% | 0.95 | 0.24 |
| NSCLC_38242124__IMC__178_A8,3 | Lung | Primary cancer | 2,949 | Tumor/Malignant cell | 42.4% | 0.91 | 0.38 |
| NSCLC_38242124__IMC__178_A8,4 | Lung | Primary cancer | 2,687 | Tumor/Malignant cell | 94.3% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_A8,5 | Lung | Primary cancer | 3,785 | Tumor/Malignant cell | 39.2% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__178_A8,6 | Lung | Primary cancer | 1,244 | Tumor/Malignant cell | 34.4% | 0.87 | 0.35 |
| NSCLC_38242124__IMC__178_A8,7 | Lung | Primary cancer | 1,427 | Tumor/Malignant cell | 76.5% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__178_A8,8 | Lung | Primary cancer | 2,823 | Tumor/Malignant cell | 45.4% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__178_B1,1 | Lung | Primary cancer | 2,934 | Tumor/Malignant cell | 88.9% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_B1,10 | Lung | Primary cancer | 2,254 | Tumor/Malignant cell | 45.4% | 0.90 | 0.36 |
| NSCLC_38242124__IMC__178_B1,11 | Lung | Primary cancer | 2,507 | Tumor/Malignant cell | 66.6% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__178_B1,12 | Lung | Primary cancer | 2,308 | Fibroblast | 28.0% | 0.59 | 0.90 |
| NSCLC_38242124__IMC__178_B1,13 | Lung | Primary cancer | 284 | Tumor/Malignant cell | 69.7% | 0.50 | 0.68 |
| NSCLC_38242124__IMC__178_B1,14 | Lung | Primary cancer | 2,785 | Tumor/Malignant cell | 35.1% | 0.91 | 0.26 |